Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
New York University School of Medicine
New York, New York
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 30
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
Daniel Young | Conflict of Interest | Syros Pharmaceuticals | >$600,000 | 2018 |
Catherine Lord | Conflict of Interest | Western Psychological Services | $250,000 - $299,999 | 2016 |
Konstantin Ichtchenko | Conflict of Interest | CytoDel, LLC | $200,000 - $249,999 | 2017 |
Thomas Tuschl | Conflict of Interest | Regulus Therapeutics Inc | $200,000 - $249,999 | 2014 |
Daniel Young | Conflict of Interest | Syros Pharmaceuticals | $100,000 - $149,999 | 2018 |
Daniel Young | Conflict of Interest | Marauder Therapeutics | $100,000 - $149,999 | 2018 |
Nathanael Gray | Conflict of Interest | Syros | $100,000 - $149,999 | 2017 |
David Rapoport | Conflict of Interest | New York University | $60,000 - $79,999 | 2016 |
David Rapoport | Conflict of Interest | New York University | $60,000 - $79,999 | 2016 |
Nathanael Gray | Conflict of Interest | Syros | $60,000 - $79,999 | 2017 |
Indu Ayappa | Conflict of Interest | New York University | $40,000 - $59,999 | 2016 |
Konstantin Ichtchenko | Conflict of Interest | CytoDel, LLC | $20,000 - $39,999 | 2016 |
Konstantin Ichtchenko | Conflict of Interest | CytoDel, LLC | $20,000 - $39,999 | 2017 |
Daniel Young | Conflict of Interest | Omega Therapeutics | $20,000 - $39,999 | 2018 |
Thomas Tuschl | Conflict of Interest | Regulus Therapeutics Inc | $20,000 - $39,999 | 2014 |
Alec Kimmelman | Conflict of Interest | Vescor Therapeutics | $20,000 - $39,999 | 2017 |
Daniel Gareau | Conflict of Interest | SurgiVance Inc. | $10,000 - $19,999 | 2017 |
Thomas Tuschl | Conflict of Interest | Max Planck Institute | $10,000 - $19,999 | 2014 |
Thomas Tuschl | Conflict of Interest | Regulus Therapeutics Inc | $0 - $4,999 | 2014 |
Preeti Raghavan | Conflict of Interest | Movease, Inc. | 2018 | |
Daniel Young | Conflict of Interest | Omega Therapeutics | 2018 | |
Alec Kimmelman | Conflict of Interest | Vescor Therapeutics LLC | 2017 | |
Philip Band | Conflict of Interest | CytoDel, LLC | 2016 | |
Konstantin Ichtchenko | Conflict of Interest | CytoDel, LLC | 2016 | |
Suman Laal | Conflict of Interest | Stellar Diagnostics India Pvt Ltd | 2017 | |
Michael Pacold | Conflict of Interest | Raze Therapeutics | 2017 | |
Alec Kimmelman | Conflict of Interest | Vescor Therapeutics | 2017 | |
Malaz Boustani | Conflict of Interest | Preferred Population Health Management, LLC | 2017 | |
Alec Kimmelman | Conflict of Interest | Vescor Therapeutics LLC | 2017 | |
Daniel Young | Conflict of Interest | Marauder Therapeutics | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.